Email Alerts
RSS
Turn off MathJax
Article Contents
Article Navigation >  CHINESE JOURNAL OF BURNS AND WOUNDS  >  > Accepted Manuscript
Zhu Feng,Guo Guanghua.Revisiting sarcopenia in older patients with refractory wounds[J].Chin J Burns Wounds,2026,42(10):1-7.DOI: 10.3760/cma.j.cn501225-20260529-00220.
Citation: Zhu Feng,Guo Guanghua.Revisiting sarcopenia in older patients with refractory wounds[J].Chin J Burns Wounds,2026,42(10):1-7.DOI: 10.3760/cma.j.cn501225-20260529-00220.
shu

Revisiting sarcopenia in older patients with refractory wounds

doi: 10.3760/cma.j.cn501225-20260529-00220
  • 1.

    Department of Critical Care Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai 200120, China

  • 2.

    Medical Center of Burn Plastic and Wound Repair, the First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang 330006, China

Funds:

National Major Difficult and Complicated Diseases Integrated Traditional Chinese and Western Medicine Clinical Collaboration Project ZDYN-2024-A-104

More Information
    Abstract
  • Sarcopenia is a major threat to the health of older patients. Older patients with refractory wounds are at increased risk of sarcopenia and have poorer outcomes, however, its clinical recognition and management remain inadequate. Based on an understanding of the bidirectional deterioration between sarcopenia and refractory wounds, healthcare professionals should draw on relevant consensus statements and guidelines, incorporate sarcopenia into routine screening, comprehensive assessment, and dynamic re-assessment, and provide integrated management encompassing nutritional support and metabolic regulation, immune and inflammatory modulation, wound care, physical activity and rehabilitation, and psychological support. Future research and clinical practice, supported by artificial intelligence and multi-omics, will be conducted to establish consensus on screening, diagnosis, and treatment for sarcopenia in older patients with refractory wounds, thereby improving their clinical outcomes and quality of life.

     

    • FullText(HTML)
  • loading
    • References(40)
  • [1]
    Cruz-JentoftAJ,BaeyensJP,BauerJM,et al.Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on sarcopenia in older people[J].Age Ageing,2010,39(4):412-423.DOI: 10.1093/ageing/afq034.
    [2]
    PapadopoulouSK.Sarcopenia: a contemporary health problem among older adult populations[J].Nutrients,2020,12(5):1293.DOI: 10.3390/nu12051293.
    [3]
    ChenLK,WooJ,AssantachaiP,et al.Asian Working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment[J].J Am Med Dir Assoc,2020,21(3):300-307.e2.DOI: 10.1016/j.jamda.2019.12.012.
    [4]
    MengS,HeX,FuX,et al.The prevalence of sarcopenia and risk factors in the older adult in China: a systematic review and meta-analysis[J].Front Public Health,2024,12:1415398.DOI: 10.3389/fpubh.2024.1415398.
    [5]
    WuX,LiX,XuM,et al.Sarcopenia prevalence and associated factors among older Chinese population: findings from the China health and retirement longitudinal study[J].PLoS One,2021,16(3):e0247617.DOI: 10.1371/journal.pone.0247617.
    [6]
    RenX,ZhangX,HeQ,et al.Prevalence of sarcopenia in Chinese community-dwelling elderly: a systematic review[J].BMC Public Health,2022,22(1):1702.DOI: 10.1186/s12889-022-13909-z.
    [7]
    崔华,王朝晖,吴剑卿,等.老年人肌少症防控干预中国专家共识(2023)[J].中华老年医学杂志,2023,42(2):144-153.DOI: 10.3760/cma.j.issn.0254-9026.2023.02.002.
    [8]
    LarssonL,DegensH,LiM,et al.Sarcopenia: aging-related loss of muscle mass and function[J].Physiol Rev,2019,99(1):427-511.DOI: 10.1152/physrev.00061.2017.
    [9]
    WangH,YangYP,LvT,et al.Prevalence and associated factors of sarcopenia in patients with diabetic foot ulcers: a systematic review and meta-analysis[J].J Foot Ankle Res,2026,19(3):e70201.DOI: 10.1002/jfa2.70201.
    [10]
    刘娟,丁清清,周白瑜,等. 中国老年人肌少症诊疗专家共识(2021)[J]. 中华老年医学杂志,2021,40(8):943-952. DOI: 10.3760/cma.j.issn.0254-9026.2021.08.001.
    [11]
    WangH, YangYP, GongLQ,et al.Study on the correlation between SINBAD system score and wound pH value in diabetic foot sarcopenia[J].J Tissue Viability,2025,34(3):100915.DOI: 10.1016/j.jtv.2025.100915.
    [12]
    VolkertD,BeckAM,CederholmT,et al.ESPEN practical guideline: clinical nutrition and hydration in geriatrics[J].Clin Nutr,2022,41(4):958-989.DOI: 10.1016/j.clnu.2022.01.024.
    [13]
    CompherC,BinghamAL,McCallM,et al.Guidelines for the provision of nutrition support therapy in the adult critically ill patient: the American Society for Parenteral and Enteral Nutrition[J].JPEN J Parenter Enteral Nutr,2022,46(1):12-41.DOI: 10.1002/jpen.2267.
    [14]
    CeredaE,VeroneseN,CaccialanzaR.Nutritional therapy in chronic wound management for older adults[J].Curr Opin Clin Nutr Metab Care,2024,27(1):3-8.DOI: 10.1097/MCO.0000000000000990.
    [15]
    AlamW,HassonJ,ReedM.Clinical approach to chronic wound management in older adults[J].J Am Geriatr Soc,2021,69(8):2327-2334.DOI: 10.1111/jgs.17177.
    [16]
    上海市抗癌协会肿瘤营养与支持治疗专业委员会,余震. 肌肉减少症规范化筛查、评估、诊断、治疗和监测技术标准[J/OL]. 肿瘤代谢与营养电子杂志,2024,11(6):782-789[2026-05-29]. https://d.wanfangdata.com.cn/periodical/CiBQZXJpb2RpY2FsQ0hJU29scjkyMDI2MDkxNTE0MjIxORIQemxkeHl5eTIwMjQwNjAwOBoIbnd5OWF5ajc%3D. DOI: 10.16689/j.cnki.cn11-9349/r.2024.06.007.
    [17]
    中华医学会老年医学分会,中国医师协会老年医学科医师分会,《中华老年医学杂志》编辑委员会. 中国老年危重患者营养支持治疗指南(2023)[J]. 中华老年医学杂志,2023,42(9):1009-1028. DOI: 10.3760/cma.j.issn.0254-9026.2023.09.001.
    [18]
    RizzoliR,BoonenS,BrandiML,et al.Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)[J].Curr Med Res Opin,2013,29(4):305-313.DOI: 10.1185/03007995.2013.766162.
    [19]
    TroeschB,EggersdorferM,LavianoA,et al.Expert opinion on benefits of long-chain omega-3 fatty acids (DHA and EPA) in aging and clinical nutrition[J].Nutrients,2020,12(9):2555.DOI: 10.3390/nu12092555.
    [20]
    CalderPC,YaqoobP.Understanding omega-3 polyunsaturated fatty acids[J].Postgrad Med,2009,121(6):148-157.DOI: 10.3810/pgm.2009.11.2083.
    [21]
    CornishSM,CordingleyDM,ShawKA,et al.Effects of omega-3 supplementation alone and combined with resistance exercise on skeletal muscle in older adults: a systematic review and meta-analysis[J].Nutrients,2022,14(11):2221.DOI: 10.3390/nu14112221.
    [22]
    ParkS,ChaeM,ParkH,et al.Higher branched-chain amino acid intake is associated with handgrip strength among Korean older adults[J].Nutrients,2021,13(5):1522.DOI: 10.3390/nu13051522.
    [23]
    LinZ,ZhaoA,HeJ.Effect of β-hydroxy-β-methylbutyrate (HMB) on the muscle strength in the elderly population: a meta-analysis[J].Front Nutr,2022,9:914866.DOI: 10.3389/fnut.2022.914866.
    [24]
    PereiraSL,ShoemakerME,GawelS,et al.Biomarker changes in response to a 12-week supplementation of an oral nutritional supplement enriched with protein, vitamin D and HMB in malnourished community dwelling older adults with sarcopenia[J].Nutrients,2022,14(6):1196.DOI: 10.3390/nu14061196.
    [25]
    BurgessJL,WyantWA,Abdo AbujamraB,et al.Diabetic wound-healing science[J].Medicina (Kaunas),2021,57(10):1072.DOI: 10.3390/medicina57101072.
    [26]
    American Diabetes Association Professional Practice Committee for Diabetes.13. Older adults: standards of care in diabetes-2026[J].Diabetes Care,2026,49(Suppl 1):S277-S296.DOI: 10.2337/dc26-S013.
    [27]
    PapadakisMA,GradyD,BlackD,et al.Growth hormone replacement in healthy older men improves body composition but not functional ability[J].Ann Intern Med,1996,124(8):708-716.DOI: 10.7326/0003-4819-124-8-199604150-00002.
    [28]
    SnyderPJ,BhasinS,CunninghamGR,et al.Effects of testosterone treatment in older men[J].N Engl J Med,2016,374(7):611-624.DOI: 10.1056/NEJMoa1506119.
    [29]
    RossouwJE,AndersonGL,PrenticeRL,et al.Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women's health initiative randomized controlled trial[J].JAMA,2002,288(3):321-333.DOI: 10.1001/jama.288.3.321.
    [30]
    Jimenez-GutierrezGE,Martínez-GómezLE,Martínez-ArmentaC,et al.Molecular mechanisms of inflammation in sarcopenia: diagnosis and therapeutic update[J].Cells,2022,11(15):2359.DOI: 10.3390/cells11152359.
    [31]
    LiangZ,ZhangL.Chronic inflammation as a driving factor for sarcopenia: an update on pathophysiology and future therapeutic targets[J].Front Pharmacol,2026,17:1733798.DOI: 10.3389/fphar.2026.1733798.
    [32]
    BianAL,HuHY,RongYD,et al.A study on relationship between elderly sarcopenia and inflammatory factors IL-6 and TNF-α[J].Eur J Med Res,2017,22(1):25.DOI: 10.1186/s40001-017-0266-9.
    [33]
    中华医学会老年医学分会,国家老年疾病临床医学研究中心(湘雅医院).中国肌肉减少症诊疗指南(2024版)[J].中华医学杂志,2025,105(3):181-203.DOI: 10.3760/cma.j.cn112137-20240724-01701.
    [34]
    王丽丽,田丽雅,牛琪,等.11种运动对老年肌少症患者身体功能改善效果的网状Meta分析[J].中华护理杂志,2022,57(21):2652-2660.DOI: 10.3761/j.issn.0254-1769.2022.21.015.
    [35]
    中华医学会老年医学分会,《中华老年医学杂志》编辑委员会. 老年人肌肉减少症体力活动管理专家共识(2026版)[J]. 中华老年医学杂志,2026,45(3):303-318. DOI: 10.3760/cma.j.issn.0254-9026.2026.03.001.
    [36]
    YogeshM,DaveA,KagatharaJ,et al.Prevalence of sarcopenia and its association with mental health status in elderly patients: a comparative cross-sectional study[J].J Midlife Health,2025,16(1):51-59.DOI: 10.4103/jmh.jmh_154_24.
    [37]
    ZhuoS,ZhangB,YangX.Association between sarcopenia-related traits and depression: an observational and Mendelian randomization analysis[J].Eur Arch Psychiatry Clin Neurosci,2026,276(2):511-526.DOI: 10.1007/s00406-025-02091-z.
    [38]
    WangDK,LiYH,GuoXM.Depression and sarcopenia-related traits: a Mendelian randomization study[J].World J Psychiatry,2023,13(11):929-936.DOI: 10.5498/wjp.v13.i11.929.
    [39]
    DaltonJT,BarnetteKG,BohlCE,et al.The selective androgen receptor modulator GTx-024 (enobosarm) improves lean body mass and physical function in healthy elderly men and postmenopausal women: results of a double-blind, placebo-controlled phase II trial[J].J Cachexia Sarcopenia Muscle,2011,2(3):153-161.DOI: 10.1007/s13539-011-0034-6.
    [40]
    RooksD,PraestgaardJ,HariryS,et al.Treatment of sarcopenia with bimagrumab: results from a phase II, randomized, controlled, proof-of-concept study[J].J Am Geriatr Soc,2017,65(9):1988-1995.DOI: 10.1111/jgs.14927.
    • Relative Articles
    • Supplements(0)
    • Cited By
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(1)

    Get Citation
    PDF
    XML

    Article Metrics

    Article views (30) PDF downloads(7) Cited by()
    Proportional views
    Related

    Copyright © Chinese Journal of Burns京ICP备07035254号-14

    E-mail：shaoshangzazhi@163.com

    Website：https://zhsszz.xml-journal.net/

    Supported by: Beijing Renhe Information Technology Co. Ltd    

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return